preview

Wnt5a Protein Regulation

Decent Essays

WNT5A is a protein encoding gene in chromosome 3p14-p21 which encodes protein WNT5A. The protein is a member of the WNT family of proteins, and is indicated to activate the planar cell polarity pathway to induce cell motility and metastasis. (15) In the embryo, the WNT5A pathway may regulate cell differentiation in morphogenesis as it is expressed in a gradient at the caudal end of the growing embryo during gastrulation. (16)
The link between up regulation of WNT5A and EMT has been well researched. Increasing expression of WNT5A shut off several other genes. One of them is KISS-1, a metastasis supressor. Another example is CD44, tumor cell homeing and metastasis antigen. Some other genes will be up regulated by WNT5A. This includes gene vimentin, …show more content…

This is believed to because more protein kinase C has been activated by WNT5A via G-protein-coupled channel which leads to influx of calcium. This calcium influx influence the EMT process which increase the mobility of the cell. (17)
In the pancreatic cancer, overall 81.3% of all patients showed up regulation of WNT5A. (18) Similary to the melanoma, patients with higher level of WNT5A expression tend to have worst tumor histological grade. It is believed WNT5A increases cancer cells migration and invasiveness both in vitro and in vivo. (18)
The mechanism of action of WNT5A is complex. As an over expression of WNT5A up regulation gene vimentin and up regulation of transciiptional repressor Snail. (19) Snail decrease transcription of gene E-cadherin, which is a class of transmembrane protein plays important in cell adhesion and forming adherens junctions. Vimentin is a protein encoded by VIM gene. It is a major cytoskeletal component of mesenchymal cells. Because of this, vimentin is often used as a marker for cells undergo epithelial-to-mesenchymal transition. Vimentin has also been used as a sarcoma tumor marker to identify mesenchyme. (20) Apart from genes being up regulated by WNT5A, several genes have been suppressed, including KISS-1 and CD44. These changes induced by WNT5A over expression appears to be related to phosphorylation of protein …show more content…

Such drugs are known as PKC inhibitors. This includes staurosporine, a microbial alkaloid and precursor to many novel PKC inhibitors which compete at PKC's ATP binding site. Newer drugds like N-benzoyl-staurosporin and -hydroxystauro-sporin improve selectivity and demonstrated better therapeutic effect in vivo. (21) The problem for existing PKC inhibitors is that they are relatively non-selective in their actions. In the future better drugs can be developed if they target specific isozymes in order to differentially inhibit PKC functions. (21) Some other researchers study the down stream products of PKC pathway, like vimentin, as a anti-cancer therapeutic target. For example, withaferin-A increases apoptosis and vimentin cleavage in vimentin expressing tumor cells and it has been proved that this drug has pronounced anti-antiogenic effect with little adverse effect in non-proliferating endothelial cells. (22) It also significantly blocks soft tissue sarcoma growth and

Get Access